AntineoplasticsRenal injury and lack of efficacy: 5 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1962卷 / 1期

关键词：

D O I：

10.1007/s40278-023-41719-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：49 / 49

相关论文

共 50 条

[1] Antihormones/antineoplasticsRenal thrombotic microangiopathy and lack of efficacy: 3 case reports
Reactions Weekly, 2023, 1966 (1) : 41 - 41
[2] AntineoplasticsRenal toxicity, neutropenia and lack of efficacy: case report
Reactions Weekly, 2023, 1945 (1) : 85 - 85
[3] Cisplatin/mannitolAcute kidney injury and lack of efficacy: 5 case reports
Reactions Weekly, 2025, 2050 (1) : 156 - 156
[4] RituximabInfection and lack of efficacy: 5 case reports
Reactions Weekly, 2023, 1938 (1) : 1130 - 1130
[5] AntineoplasticsNeutropenia and lack of efficacy: 5 case reports
Reactions Weekly, 2023, 1942 (1) : 39 - 39
[6] TemozolomideNecrosis and lack of efficacy: 5 case reports
Reactions Weekly, 2022, 1935 (1) : 379 - 379
[7] MidostaurinThrombocytosis and lack of efficacy: 5 case reports
Reactions Weekly, 2023, 1946 (1) : 342 - 342
[8] AntineoplasticsInfection and lack of efficacy: 5 case reports
Reactions Weekly, 2022, 1930 (1) : 60 - 60
[9] AntineoplasticsLive injury and lack of efficacy: 2 case reports
Reactions Weekly, 2022, 1915 (1) : 56 - 56
[10] AntineoplasticsRenal dysfunction, creatine kinase elevation and lack of efficacy: case report
Reactions Weekly, 2023, 1953 (1) : 60 - 60

← 1 2 3 4 5 →